Heterocyclic tripeptides as hepatitis c inhibitors

Details for Australian Patent Application No. 2003202348 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Bailey, Murray, D.; Ghiro, Elise; LlinasBrunet, Montse

Agent Davies Collison Cave

Pub. Number AU-B-2003202348

PCT Number PCT/CA03/00091

PCT Pub. Number WO2003/064416

Priority 2,369,970 01.02.02 CA

Filing date 24 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 17 January 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7056 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 2,369,970 01.02.02 CA

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202348

17 January 2008 Application Accepted

  Published as AU-B-2003202348

15 May 2008 Standard Patent Sealed

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202349-Methods and apparatus for reestablishing communication for a wireless communication device after a communication loss in a wireless communication network

2003202347-Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (Hepatitis C)